Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease. In patients with IPF,
cough is one of the most disabling symptoms and is an independent predictor of disease …

Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive and ultimately fatal lung
disease. The combination of poor prognosis, uncertainty of disease course and severe …

Assessment of health-related quality of life (HRQL) is particularly important in patients with
progressive and incurable diseases such as idiopathic pulmonary fibrosis (IPF). The St …

Background Patients with fibrotic interstitial lung disease have symptom control and quality
of life (QoL) needs. This review aims to evaluate the evidence for the use of interventions in …

Interstitial lung disease (ILD) is a group of chronic respiratory diseases characterized by
dyspnoea on exertion and decline in health-related quality of life (HRQL). People with ILD …

The effects of interstitial lung disease (ILD) create a significant burden on patients, unsettling
almost every domain of their lives, disrupting their physical and emotional well-being and …

Background Neoadjuvant chemoradiotherapy (nCRT) plus surgery is a standard of care for
patients with esophageal or junctional cancer, but the long-term impact of nCRT on health …

Health-related quality of life or health status is significantly impaired in bronchiectasis. There
is a paucity of brief, simple-to-use, disease-specific health status measures. The aim of this …

Background Patients with idiopathic pulmonary fibrosis (IPF) have impaired health-related
quality of life (HRQL). To measure HRQL, an IPF-specific version of the St. George's …

In idiopathic pulmonary fibrosis (IPF), home monitoring experiences are limited, not yet real-
time available nor implemented in daily care. We evaluated feasibility and potential barriers …